Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Antibody detection by agglutination-PCR (ADAP) enables early diagnosis of HIV infection by oral fluid analysis.

Tsai CT, Robinson PV, Cortez FJ, Elma MLB, Seftel D, Pourmandi N, Pandori MW, Bertozzi CR.

Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):1250-1255. doi: 10.1073/pnas.1711004115. Epub 2018 Jan 22.

2.

Implementation of a Rapid Genotypic Assay to Promote Targeted Ciprofloxacin Therapy of Neisseria gonorrhoeae in a Large Health System.

Allan-Blitz LT, Humphries RM, Hemarajata P, Bhatti A, Pandori MW, Siedner MJ, Klausner JD.

Clin Infect Dis. 2017 May 1;64(9):1268-1270. doi: 10.1093/cid/ciw864.

3.

Stemming the tide of drug-resistant Neisseria gonorrhoeae: the need for an individualized approach to treatment.

Buono SA, Watson TD, Borenstein LA, Klausner JD, Pandori MW, Godwin HA.

J Antimicrob Chemother. 2015 Feb;70(2):374-81. doi: 10.1093/jac/dku396. Epub 2014 Oct 19. Review.

PMID:
25331059
4.

Performance of rapid point-of-care and laboratory tests for acute and established HIV infection in San Francisco.

Pilcher CD, Louie B, Facente S, Keating S, Hackett J Jr, Vallari A, Hall C, Dowling T, Busch MP, Klausner JD, Hecht FM, Liska S, Pandori MW.

PLoS One. 2013 Dec 12;8(12):e80629. doi: 10.1371/journal.pone.0080629. eCollection 2013.

5.

The Multispot rapid HIV-1/HIV-2 differentiation assay is comparable with the Western blot and an immunofluorescence assay at confirming HIV infection in a prospective study in three regions of the United States.

Pandori MW, Westheimer E, Gay C, Moss N, Fu J, Hightow-Weidman LB, Craw J, Hall L, Giancotti FR, Mak ML, Madayag C, Tsoi B, Louie B, Patel P, Owen SM, Peters PJ.

J Clin Virol. 2013 Dec;58 Suppl 1:e92-6. doi: 10.1016/j.jcv.2013.10.006.

6.

Characteristics of males infected with common Neisseria gonorrhoeae sequence types in the Gonococcal Isolate Surveillance Project, San Francisco, California, 2009.

Bernstein KT, Marcus JL, Barry PM, Pandori MW, Buono S, Hess D, Philip SS.

Am J Epidemiol. 2013 Oct 15;178(8):1289-95. doi: 10.1093/aje/kwt115. Epub 2013 Sep 18.

PMID:
24049157
7.

Using the Neisseria gonorrhoeae multiantigen sequence-typing method to assess strain diversity and antibiotic resistance in San Francisco, California.

Buono S, Wu A, Hess DC, Carlson JS, Rauch L, Philip SS, Barry P, Bernstein K, Klausner JD, Pandori MW.

Microb Drug Resist. 2012 Oct;18(5):510-7. doi: 10.1089/mdr.2011.0229. Epub 2012 Jun 11.

PMID:
22686196
8.

Clinical Neisseria gonorrhoeae isolates in the United States with resistance to azithromycin possess mutations in all 23S rRNA alleles and the mtrR coding region.

Wu A, Buono S, Katz KA, Pandori MW.

Microb Drug Resist. 2011 Sep;17(3):425-7. doi: 10.1089/mdr.2010.0199. Epub 2011 Apr 14.

PMID:
21492017
9.

Evaluation of an IgM/IgG sensitive enzyme immunoassay and the utility of index values for the screening of syphilis infection in a high-risk population.

Wong EH, Klausner JD, Caguin-Grygiel G, Madayag C, Barber KO, Qiu JS, Liska S, Pandori MW.

Sex Transm Dis. 2011 Jun;38(6):528-32. doi: 10.1097/OLQ.0b013e318205491a.

PMID:
21233789
10.

2010 HIV Diagnostics Conference.

Pandori MW, Branson BM.

Expert Rev Anti Infect Ther. 2010 Jun;8(6):631-3. doi: 10.1586/eri.10.48.

PMID:
20521890
11.

Prevalence and correlates of Trichomonas vaginalis among incarcerated persons assessed using a highly sensitive molecular assay.

Freeman AH, Katz KA, Pandori MW, Rauch LM, Kohn RP, Liska S, Bernstein KT, Klausner JD.

Sex Transm Dis. 2010 Mar;37(3):165-8. doi: 10.1097/OLQ.0b013e3181bcd3fc.

PMID:
20023598
12.

Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting.

Pandori MW, Hackett J Jr, Louie B, Vallari A, Dowling T, Liska S, Klausner JD.

J Clin Microbiol. 2009 Aug;47(8):2639-42. doi: 10.1128/JCM.00119-09. Epub 2009 Jun 17.

13.

Assessment of sensitivity and specificity of first, second, and third generation EIA for the detection of antibodies to HIV-1 in oral fluid.

Louie B, Lei J, Liska S, Dowling T, Pandori MW.

J Virol Methods. 2009 Jul;159(1):119-21. doi: 10.1016/j.jviromet.2009.02.016. Epub 2009 Feb 24.

PMID:
19442855
14.

Screening and confirmation of human immunodeficiency virus type 1 infection solely by detection of RNA.

Ren A, Louie B, Rauch L, Castro L, Liska S, Klausner JD, Pandori MW.

J Med Microbiol. 2008 Oct;57(Pt 10):1228-33. doi: 10.1099/jmm.0.2008/002386-0.

PMID:
18809550
15.

Assessment of rapid tests for detection of human immunodeficiency virus-specific antibodies in recently infected individuals.

Louie B, Wong E, Klausner JD, Liska S, Hecht F, Dowling T, Obeso M, Phillips SS, Pandori MW.

J Clin Microbiol. 2008 Apr;46(4):1494-7. doi: 10.1128/JCM.01945-07. Epub 2008 Jan 30.

16.

Detection of azithromycin resistance in Treponema pallidum by real-time PCR.

Pandori MW, Gordones C, Castro L, Engelman J, Siedner M, Lukehart S, Klausner J.

Antimicrob Agents Chemother. 2007 Sep;51(9):3425-30. Epub 2007 Jul 9.

17.

Real-Time PCR for detection of herpes simplex virus without nucleic acid extraction.

Pandori MW, Lei J, Wong EH, Klausner J, Liska S.

BMC Infect Dis. 2006 Jun 24;6:104.

20.

In situ transduction of target cells on solid surfaces by immobilized viral vectors.

Hobson DA, Pandori MW, Sano T.

BMC Biotechnol. 2003 May 9;3:4. Epub 2003 May 9.

21.

Photochemical control of the infectivity of adenoviral vectors using a novel photocleavable biotinylation reagent.

Pandori MW, Hobson DA, Olejnik J, Krzymanska-Olejnik E, Rothschild KJ, Palmer AA, Phillips TJ, Sano T.

Chem Biol. 2002 May;9(5):567-73.

22.

A chimera of a gelatinase inhibitor peptide with streptavidin as a bifunctional tumor targeting reagent.

Farlow SJ, Wang RJ, Pandori MW, Sano T.

FEBS Lett. 2002 Apr 10;516(1-3):197-200.

23.

Photoactivatable retroviral vectors: a strategy for targeted gene delivery.

Pandori MW, Sano T.

Gene Ther. 2000 Dec;7(23):1999-2006.

24.
25.

The dileucine-based sorting motif in HIV-1 Nef is not required for down-regulation of class I MHC.

Riggs NL, Craig HM, Pandori MW, Guatelli JC.

Virology. 1999 Jun 5;258(2):203-7.

26.
27.

Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein.

Pandori MW, Fitch NJ, Craig HM, Richman DD, Spina CA, Guatelli JC.

J Virol. 1996 Jul;70(7):4283-90.

28.
29.

Supplemental Content

Loading ...
Support Center